FDA Announces New Safety Controls for Long-Acting Beta Agonists, Medications Used to Treat Asthma

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: FDA Announces New Safety Controls for Long-Acting Beta Agonists, Medications Used to Treat Asthma

FDA Announces New Safety Controls for Long-Acting Beta Agonists, Medications Used to Treat Asthma
Thu, 18 Feb 2010 11:00:00 -0600

The U.S. Food and Drug Administration today announced that drugs in the class of long-acting beta agonists (LABAs) should never be used alone in the treatment of asthma in children or adults. Manufacturers will be required to include this warning in the product labels of these drugs, along with taking other steps to reduce the overall use of these medications.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@xxxxxxxxxxxxxxx
• Other inquiries? webmail@xxxxxxxxxx

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420